EZH2-Associated Hypermethylated Gene Signature Predicts Immunotherapy Response and Implicates DUSP5 in Tumor-Immune Regulation in Triple-Negative Breast Cancer.

Saved in:
Bibliographic Details
Title: EZH2-Associated Hypermethylated Gene Signature Predicts Immunotherapy Response and Implicates DUSP5 in Tumor-Immune Regulation in Triple-Negative Breast Cancer.
Authors: Xue, Mingzhan1 (AUTHOR), Jeya, Sujitha1,2 (AUTHOR), Elasad, Reem1 (AUTHOR), Mestiri, Sarra1,2 (AUTHOR), Al Ejeh, Fares1,2 (AUTHOR), Al-Muftah, Mariam1,2 (AUTHOR) maalmuftah@hbku.edu.qa
Source: Cancers. May2026, Vol. 18 Issue 10, p1606. 21p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:20726694
DOI:10.3390/cancers18101606